- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04048499
Prevalence and Severity of Colour Vision Deficiency Among Turkish Children
August 7, 2019 updated by: Funda Dikkaya, Medipol University
To evaluate the usability of the Colour Assessment and Diagnosis (CAD) test in children.
To determine the prevalence of colour vision deficiency (CVD) among Turkish children, to identify the class of deficiency and to quanify severity of loss.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
1374
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey
- İstanbul Medipol University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 14 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
A total of 1374 children, aged 6-16 years, who attended the ophthalmology department at the Istanbul Medipol University were included in the study.
Description
Inclusion Criteria: children with aged 6-16 years, who attended the ophthalmology department at the Istanbul Medipol University -
Exclusion Criteria:Children with known or current evidence of ocular pathology (other than refractive errors), with history of long term use of medication, previous ocular surgery and those with chronic systemic diseases were excluded from the study
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prevalence and Severity of Colour Vision Deficiency among Turkish Children
Time Frame: january 2018-march 2019
|
number of children with colour vision deficiency (CVD) among Turkish children who attend to the clinic in a period o time, number of children in each class of deficiency (protan, deutan) and number of children in each category according to severity.
|
january 2018-march 2019
|
|
the usability of the Colour Assessment and Diagnosis (CAD) test in children
Time Frame: january 2018-march 2019
|
number of children who were cooperative and carried out the full CAD test
|
january 2018-march 2019
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2018
Primary Completion (Actual)
March 1, 2019
Study Completion (Actual)
March 1, 2019
Study Registration Dates
First Submitted
August 6, 2019
First Submitted That Met QC Criteria
August 6, 2019
First Posted (Actual)
August 7, 2019
Study Record Updates
Last Update Posted (Actual)
August 9, 2019
Last Update Submitted That Met QC Criteria
August 7, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 425
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on CAD Test; Children's Vision; Colour Assessment; Colour Vision; Turkey
-
Universidad de ExtremaduraNot yet recruitingDisabilities | Visual Impairment and Blindness (Excl Colour Blindness)
-
Yanyun ZhangCompletedVisual Impairment and Blindness (Excl Colour Blindness)China
-
Dot Glasses KenyaQueen's University, Belfast; University of Stellenbosch; Sun King; Livelihood Impact...Not yet recruitingPresbyopia Correction | Livelihoods | Visual Impairment and Blindness (Excl Colour Blindness) | Repayment Behaviour
Clinical Trials on the Colour Assessment and Diagnosis (CAD) test
-
Kasr El Aini HospitalCompletedLupus Glomerulonephritis | Systemic Lupus Erthematosus | Lupus FlareEgypt
-
Shandong UniversityLinyi County People's Hospital,Dezhou,ChinaRecruitingArtificial Intelligence | Endoscopy | Atrophic GastritisChina
-
Theodor Bilharz Research InstituteRecruitingColorectal CancerEgypt
-
Centre Hospitalier Universitaire DijonRecruitingFrontotemporal Lobar Degeneration (FTLD)France
-
Haute Ecole de Santé VaudUniversity of Applied Sciences of Western SwitzerlandCompletedMultiple SclerosisSwitzerland
-
AGIR à DomCompleted
-
Faculty Hospital Kralovske VinohradyEnrolling by invitationDementia | Mild Cognitive Impairment (MCI) | Frontotemporal Degeneration (FTD) | Alzheimer Disease (AD) | Mild Cognitive Impairment (MCI) AmnesticCzechia
-
Universitair Ziekenhuis BrusselCompletedAsthma | Adherence, Medication | COPDBelgium
-
Montreal Heart InstituteCompleted
-
University Hospital, GrenobleCompletedAnkle Injuries | Treatment | Foot Injuries | DiagnosisFrance